EverSource Wealth Advisors’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8K | Buy |
4,672
+4,480
| +2,333% | +$23.8K | ﹤0.01% | 2124 |
|
|
2025
Q1 | $1.7K | Sell |
192
-165
| -46% | -$1.46K | ﹤0.01% | 2991 |
|
|
2024
Q4 | $4.89K | Sell |
357
-124
| -26% | -$1.7K | ﹤0.01% | 2361 |
|
|
2024
Q3 | $13.2K | Hold |
481
| – | – | ﹤0.01% | 1714 |
|
|
2024
Q2 | $13.5K | Buy |
481
+13
| +3% | +$364 | ﹤0.01% | 1704 |
|
|
2024
Q1 | $9.16K | Buy |
468
+5
| +1% | +$98 | ﹤0.01% | 1735 |
|
|
2023
Q4 | $8.86K | Buy |
463
+241
| +109% | +$4.61K | ﹤0.01% | 1615 |
|
|
2023
Q3 | $3.56K | Sell |
222
-645
| -74% | -$10.3K | ﹤0.01% | 1827 |
|
|
2023
Q2 | $20.1K | Buy |
867
+155
| +22% | +$3.59K | ﹤0.01% | 1150 |
|
|
2023
Q1 | $16.5K | Buy |
712
+273
| +62% | +$6.34K | ﹤0.01% | 1152 |
|
|
2022
Q4 | $6.37K | Sell |
439
-69
| -14% | -$1K | ﹤0.01% | 1506 |
|
|
2022
Q3 | $9K | Buy |
+508
| New | +$9K | ﹤0.01% | 1158 |
|